Trials / Withdrawn
WithdrawnNCT02406417
Reflective Testing for Early Diagnosis of Pituitary Dysfunction
The Use of Reflex Strategies and Reflective Testing in the Clinical Chemistry Laboratory for Early Detection of Pituitary Dysfunction in Patients From Primary Care.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Nova Scotia Health Authority · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Early detection and management of pituitary dysfunction reduces the morbidity that ensues as a consequence of missed or delayed diagnosis of this condition, and which may result in life-threatening events and increased mortality. The investigators study will explore the use of reflex strategies within the laboratory in capturing suspicious pituitary function test results from Primary Care patients and following these up with appropriate reflective testing. Subsequently patients identified from these results to have a possible underlying piuitary dysfunction will have an alert sent to their family physician prompting referral to the Endocrine team for further investigation and management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigation for pituitary dysfunction by blood tests. | Blood tests for pituitary function (one or more of the following tests: cortisol, LH, FSH, TSH, FT4, testosterone, prolactin) will be added to samples from patients identified as being at high risk from their initial blood results. |
| DEVICE | Dynamic function tests and pituitary imaging | Patients identified as being highly likely to have a pituitary dysfunction from the results of the blood tests for pituitary function added, will be referred to the Endocrine team for further tests in the form of dynamic function tests and pituitary imaging. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-04-02
- Last updated
- 2024-08-21
Source: ClinicalTrials.gov record NCT02406417. Inclusion in this directory is not an endorsement.